We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
RESEARCH SUPPORT, U.S. GOV'T, P.H.S.
The intrauterine device and pelvic inflammatory disease revisited: new results from the Women's Health Study.
Obstetrics and Gynecology 1988 July
To examine whether the risk of pelvic inflammatory disease associated with intrauterine device (IUD) use varies with a woman's sexual behavior, we analyzed data from the Women's Health Study, a hospital-based, case-control study carried out in the United States from 1976-1978. The cases were 657 women hospitalized with pelvic inflammatory disease; controls were 2566 women hospitalized with nongynecologic conditions. After controlling for confounding factors, we found no consistent differences in the risk of pelvic inflammatory disease associated with IUD use among women in different categories of gonorrhea history, frequency of intercourse, or number of recent sexual partners. However, among women with only one sexual partner, married and cohabiting women had little appreciable increased pelvic inflammatory disease risk associated with IUD use compared with those using no contraception, whereas previously and never-married women using IUDs had relative risk estimates of 1.8 and 2.6, respectively. These results suggest that women at low risk of acquiring sexually transmitted infections have little increase in the risk of pelvic inflammatory disease from use of an IUD.
Full text links
Related Resources
Trending Papers
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Anti-Arrhythmic Effects of Heart Failure Guideline-Directed Medical Therapy and Their Role in the Prevention of Sudden Cardiac Death: From Beta-Blockers to Sodium-Glucose Cotransporter 2 Inhibitors and Beyond.Journal of Clinical Medicine 2024 Februrary 27
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app